Cause of death: A "broken" MEKK?

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 5, 2006, Pages 593-596

  Sussman, Mark A ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; PROTEIN P53; CASP3 PROTEIN, HUMAN; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1;

ANOIKIS; APOPTOSIS; CAUSE OF DEATH; EDITORIAL; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIA; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; HEART MUSCLE; METABOLISM; NOTE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; HUMANS; MAP KINASE KINASE 1; MODELS, BIOLOGICAL; MYOCARDIUM; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33646091527     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.01.001     Document Type: Editorial

References (45)

1. Logue S.E., Gustafsson A.B., Samali A., and Gottlieb R.A. Ischemia/reperfusion injury at the intersection with cell death. J. Mol. Cell. Cardiol. 38 (2005) 21-33 (Review)
2. Honda H.M., Korge P., and Weiss J.N. Mitochondria and ischemia/reperfusion injury. Ann. N. Y. Acad. Sci. 1047 (2005) 248-258 (Review)
3. Zhao Z.Q., Velez D.A., Wang N.P., Hewan-Lowe K.O., Nakamura M., Guyton R.A., et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 6 (2001) 279-290
4. Lemasters J.J. The mitochondrial permeability transition and the calcium, oxygen and pH paradoxes: one paradox after another. Cardiovasc. Res. 44 (1999) 470-473 (Review)
5. Kawabata K.I., Netticadan T., Osada M., Tamura K., and Dhalla N.S. Mechanisms of ischemic preconditioning effects on Ca(2+) paradox-induced changes in heart. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1008-H1015
6. Buja L.M. Myocardial ischemia and reperfusion injury. Cardiovasc. Pathol. 14 (2005) 170-175 (Review)
7. Gustafsson A.B., and Gottlieb R.A. Mechanisms of apoptosis in the heart. J. Clin. Immunol. 23 (2003) 447-459 (Review)
8. Stephanou A. Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. J. Cell. Mol. Med. 8 (2004) 519-525 (Review)
9. Cannon III R.O. Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med. 2 (2005) 88-94 (Review)
10. Ruetten H., Badorff C., Ihling C., Zeiher A.M., and Dimmeler S. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. J. Am. Coll. Cardiol. 38 (2001) 2063-2070
11. Grunenfelder J., Miniati D.N., Murata S., Falk V., Hoyt E.G., Kown M., et al. Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts. Circulation 104 (2001) I202-I206
12. Naka Y., Sawa Y., Nishimura M., Hirata N., Ueda H., Ohtake S., et al. Participation of caspase-3-like protease in necrotic cell death of myocardium during ischemia-reperfusion injury in rat hearts. Circ. J. 67 (2003) 248-252
13. Bott-Flugel L., Weig H.J., Knodler M., Stadele C., Moretti A., Laugwitz K.L., et al. Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function. J. Mol. Med. 83 (2005) 526-534
14. Zebrowski D.C., Alcendor R.R., Kirschenbaum L.A., and Sadoshima J. Caspase-3 mediated cleavage of MEKK1 promotes p53 transcriptional activity. J. Mol. Cell. Cardiol. (2006) (??)
15. Song H., Conte Jr. J.V., Foster A.H., McLaughlin J.S., and Wei C. Increased p53 protein expression in human failing myocardium. J. Heart Lung Transplant. 18 (1999) 744-749
16. Chandrashekhar Y., Sen S., Anway R., Shuros A., and Anand I. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. J. Am. Coll. Cardiol. 43 (2004) 295-301
17. Cardone M.H., Alvesen G.S., Widmann C., Johnson G., and Frisch S.M. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90 (1997) 315-323
18. Widmann C., Gerwins P., Johnson N.L., Jarpe M.B., and Johnson G.L. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 18 (1998) 2416-2429
19. Yang J.Y., and Widmann C. A subset of caspase substrates functions as the Jekyll and Hyde of apoptosis. Eur. Cytokine Netw. 13 (2002) 404-406
20. Ramirez M.T., Sah V.P., Zhao X.L., Hunter J.J., Chien K.R., and Brown J.H. The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J. Biol. Chem. 272 (1997) 14057-14061
21. Sadoshima J., Montagne O., Wang Q., Yang G., Warden J., Liu J., et al. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J. Clin. Invest. 110 (2002) 271-279
22. Andreka P., Zang J., Dougherty C., Slepak T.I., Webster K.A., and Bishopric N.H. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ. Res. 88 (2001) 305-312
23. Tindberg N., Porsmyr-Palmertz M., and Simi A. Contribution of MAP kinase pathways to the activation of ATF-2 in human neuroblastoma cells. Neurochem. Res. 25 (2000) 527-531
24. Bialik S., Geenen D.L., Sasson I.E., Cheng R., Horner J.W., Evans S.M., et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J. Clin. Invest. 100 (1997) 1363-1372
25. Webster K.A., Discher D.J., Kaiser S., Hernandez O., Sato B., and Bishopric N.H. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. J. Clin. Invest. 104 (1999) 239-252
26. Xie Z., Koyama T., Abe K., Fujii Y., Sawa H., and Nagashima K. Uprgulation of p53 protein in rat heart subjected to a transient occlusion of the coronary artery followed by reperfusion. Jpn. J. Physiol. 50 (2000) 159-162
27. Pierzchalski P., Reiss K., Cheng W., Cirielli C., Kajstura J., Nitahara J.A., et al. p53 Induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp. Cell Res. 234 (1997) 57-65
28. Long X., Boluyt M.O., Hipolito M.L., Lundberg M.S., Zheng J.S., O'Neill L., et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J. Clin. Invest. 99 (1997) 2635-2643
29. Leri A., Fiordaliso F., Setoguchi M., Limana F., Bishopric N.H., Kajstura J., et al. Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis. Am. J. Pathol. 157 (2000) 843-857
30. Regula K.M., and Kirshenbaum L.A. p53 activates the mitochondrial death pathway and apoptosis of ventricular myocytes independent of de novo gene transcription. J. Mol. Cell. Cardiol. 33 (2001) 1435-1445
31. Fuchs S.Y., Adler V., Pincus M.R., and Ronai Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA 95 (1998) 10541-10546
32. Grossman J. Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 7 (2002) 247-260
33. Frisch S.M., and Ruoslahti E. Integrins and anoikis. Curr. Opin. Cell Biol. 9 (1997) 701-706
34. Ikeda H., Suzuki Y., Suzuki M., Koike M., Tamura J., Tong J., et al. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut 42 (1998) 530-537
35. Kaiser R.A., Liang Q., Bueno O., Huang Y., Lackey T., Klevitsky R., et al. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. J. Biol. Chem. 280 (2005) 32602-32608
36. Shao Z, Bhattacharya K, Hsich E, Park L, Walters B, Germann U, et al. c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ. Res. 2005; [Epub ahead of print].
37. Frisch S.M., Vuori K., Kelaita D., and Sicks S. A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA. J. Cell Biol. 135 (1996) 1377-1382
38. Widmann C., Gibson S., and Johnson G.L. Caspase-dependent cleavage of signaling proteins during apoptosis. J. Biol. Chem. 273 (1998) 7141-7147
39. Toth A., Nickson P., Qin L.L., and Erhardt P. Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J. Biol. Chem. (2005) [Epub ahead of print]
40. Uchiyama T., Engelman R.M., Maulik N., and Das D.K. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation 109 (2004) 3042-3049
41. Vinten-Johansen J., Zhao Z.Q., Zatta A.J., Kin H., Halkos M.E., and Kerendi F. Postconditioning-a new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res. Cardiol. 100 (2005) 295-310 (Review)
42. Hausenloy D.J., Tsang A., and Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc. Med. 15 (2005) 69-75 (Review)
43. Bachelder R.E., Wendt M.A., Fujita N., Tsuruo T., and Mercurio A.M. The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis. J. Biol. Chem. 276 (2001) 34702-34707
44. Takada Y., Hashimoto M., Kasahara J., Aihara K., and Fukunaga K. Cytoprotective effect of sodium orthovanadate on ischemia/reperfusion-induced injury in the rat heart involves Akt activation and inhibition of fodrin breakdown and apoptosis. J. Pharmacol. Exp. Ther. 311 (2004) 1249-1255
45. Gibson E.M., Henson E.S., Villanueva J., and Gibson S.B. MEK kinase 1 induces mitochondrial permeability transition leading to apoptosis independent of cytochrome c release. J. Biol. Chem. 277 (2002) 10573-10580